Research Study

An Open-label, Single-arm, Multi-centre, Long-term Extension Trial to Evaluate the Safety and Efficacy of Tralokinumab in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Clinical Trials
Principal Investigator 
Sunil Kalia

Overview

Body Locations and Systems 
Dermatitis
ClinicalTrials.gov# 
NCT03587805
Status 
Recruiting
Study Start/End 
Mar 28, 2019 to Jul 31, 2019
Locations 
Vancouver General Hospital
Phone 
604-875-5296
Purpose of Study 

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab in patients with atopic dermatitis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.